JA Solar Holdings Swings to Profit in Q4 and Hits 52-Week High

Joel Anderson |

JA Solar Holdings (JASO) , a small-cap Chinese company that manufactures solar panels, released a highly-anticipated Q4 2013 earnings report on Monday and didn’t disappoint, swinging to profit and reaching a new 52-week high in early trading.

JA Solar Holdings reported profits, notable for a company that hasn’t been in the black since 2010. The improvements over Q3 of 2013 were dramatic.

JA Solar reported profits of $0.16 per share, up from a $0.37 a share loss just a quarter earlier. Net revenue climbed to $357.3 million from $290.5 million in Q3. The company shipped 665.5 megawatts of capacity in the quarter, well above Q3’s 500.2 MW and the high end of previously issued guidance which was 550 MW.

"The growth from China and Japan is definitely sustainable as more than 80 percent of their revenue has come from the Asia Pacific region," S&P Capital analyst Angelo Zino said.

Shares gapped up $1.40 apiece to $12.82 with the opening bell, and kept gaining until they peaked out at $13.14 a share, the highest level they’ve reached in two years. This comes after speculation about this earnings report drove shares higher on Friday. The stock retreated from its peak, but was still trading up more than 5 percent at about $12 a share by early afternoon.

Volume was also extremely heavy on Monday, with more than 15 million shares moved by 1 pm compared to an average daily volume of just over 2.5 million shares.

"We continued to perform well in all of our key regions in the fourth quarter, notably China, which is proving to be one of the cornerstone markets of global solar demand," said CEO Baofang Jin in a statement.

JA Solar Holdings has taken full advantage of the salad days for solar that date back to the bottom of the market in late 2012. Despite the brewing trade war between the United States and China, solar has shown tremendous growth over the last 18 months. Since the start of 2013, shares in JA Solar Holdings have nearly triple in value.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Spotlight

BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Events

EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more

Research

MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…